1. Home
  2. BRCB vs LCTX Comparison

BRCB vs LCTX Comparison

Compare BRCB & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRCB

Black Rock Coffee Bar Inc.

N/A

Current Price

$14.06

Market Cap

225.8M

Sector

N/A

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCB
LCTX
Founded
2008
1990
Country
United States
United States
Employees
2800
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.8M
391.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BRCB
LCTX
Price
$14.06
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$26.83
$5.33
AVG Volume (30 Days)
372.0K
1.0M
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$30.74
$109.40
Revenue Next Year
$24.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$11.51
$0.40
52 Week High
$30.40
$2.09

Technical Indicators

Market Signals
Indicator
BRCB
LCTX
Relative Strength Index (RSI) 47.67 54.57
Support Level $13.53 $1.56
Resistance Level $17.60 $1.82
Average True Range (ATR) 0.81 0.08
MACD 0.10 0.02
Stochastic Oscillator 68.44 76.60

Price Performance

Historical Comparison
BRCB
LCTX

About BRCB Black Rock Coffee Bar Inc.

Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: